CIK 0001745999 · Large accelerated filer
Beam Therapeutics Inc.
Sign in to watch- Ticker
- BEAM
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 857-327-8775
- Business address
- 26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
- Former names
- Beam Therapeutics Inc.
- 4 Planned sale Chief Legal Officer sold 385 shares at $23.48 ($9,040)
- 4 Planned sale SVP, Finance and Treasurer sold 289 shares at $23.48 ($6,785)
- 4 Planned sale CEO sold 60,000 shares at $24.60 ($1,476,024)
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 8-K Event Executive or director change
- 4 Planned sale Chief Medical Officer sold 1,250 shares at an average $23.28 ($29,094)
- 4 Planned sale CEO sold 60,000 shares at $24.50 ($1,470,156)
- 144 Insider Sale of Securities
- 8-K Event Shareholder vote results
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 10-Q Report Quarterly Report
Page 10 of 26 · 514 filings